Literature DB >> 24899985

What are the Best Ways to Reduce the False-positive Rate of 18F-FDG PET/CT in Patients with Breast Cancer?

Laura Evangelista1, Zora Baretta2, Lorenzo Vinante1, Guido Sotti1.   

Abstract

Entities:  

Year:  2011        PMID： 24899985      PMCID： PMC4042954          DOI： 10.1007/s13139-010-0072-6

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN： 1869-3474


× No keyword cloud information.
  8 in total

1.  Whole-body (18)F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patients.

Authors:  Duska Vranjesevic; Jean Emmanuel Filmont; Joubin Meta; Daniel H Silverman; Michael E Phelps; Jyotsna Rao; Peter E Valk; Johannes Czernin
Journal:  J Nucl Med       Date:  2002-03       Impact factor: 10.057

2.  PET/CT: a new road map.

Authors:  Peter J Ell; Gustav K von Schulthess
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-04-24       Impact factor: 9.236

Review 3.  Can PET/CT replace separate diagnostic CT for cancer imaging? Optimizing CT protocols for imaging cancers of the chest and abdomen.

Authors:  Hilmar Kuehl; Patrick Veit; Sandra J Rosenbaum; Andreas Bockisch; Gerald Antoch
Journal:  J Nucl Med       Date:  2007-01       Impact factor: 10.057

4.  Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck.

Authors:  R Hustinx; R J Smith; F Benard; D I Rosenthal; M Machtay; L A Farber; A Alavi
Journal:  Eur J Nucl Med       Date:  1999-10

5.  Initial experience with FDG-PET/CT in the evaluation of breast cancer.

Authors:  Mitsuaki Tatsumi; Christian Cohade; Karen A Mourtzikos; Elliot K Fishman; Richard L Wahl
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-10-29       Impact factor: 9.236

6.  A combined PET/CT scanner for clinical oncology.

Authors:  T Beyer; D W Townsend; T Brun; P E Kinahan; M Charron; R Roddy; J Jerin; J Young; L Byars; R Nutt
Journal:  J Nucl Med       Date:  2000-08       Impact factor: 10.057

Review 7.  FLT: measuring tumor cell proliferation in vivo with positron emission tomography and 3'-deoxy-3'-[18F]fluorothymidine.

Authors:  Alexander Salskov; Varaha S Tammisetti; John Grierson; Hubert Vesselle
Journal:  Semin Nucl Med       Date:  2007-11       Impact factor: 4.446

8.  Normal Physiologic and Benign Foci with F-18 FDG Avidity on PET/CT in Patients with Breast Cancer.

Authors:  Soon-Ah Park; Kwang-Man Lee; UnJong Choi; Hun Soo Kim; Hye-Won Kim; Jeong Hoon Song
Journal:  Nucl Med Mol Imaging       Date:  2010-10-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.